hotspot -WSS

hotspot

author：focus 2025-10-01 00:17:00 - browse：5

Verve Therapeutics said Sunday that the first 10 people to receive a one-time treatment powered by a form of CRISPR called base editing showed reductions in bad cholesterol levels — study results that are preliminary but signal the potential for gene-editing treatments to benefit people with an inherited type of cardiovascular disease.

Three of the study participants treated with potentially therapeutic doses of the Verve drug, called VERVE-101, showed reductions in LDL-C levels of 39%, 48%, and 55%, respectively. The latter patient’s decline in so-called “bad” cholesterol was maintained for six months.

The Verve-101 study results were presented at the American Heart Association conference and are the first data in patients from a therapy that uses base editing to change individual letters of DNA. Verve licensed the base-editing technology from Beam Therapeutics.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： Eli Lilly’s Zepbound improved liver scarring in mid

WSS

For pregnant people, addiction treatment shouldn't mean a call to child protective services

STAT wants to know your pick for a great summer read or listen

Congress needs to close a vaccine

FDA approves Moderna’s RSV vaccine, its second licensed product

Structure Therapeutics oral GLP

Elevance PBM president out as customers face prescription chaos

focus

hotspot

focus

Anesthesiologist group: stop taking Ozempic before surgery

UnitedHealth CEO's Medicaid comments send insurer stocks diving

The cancer drug shortage isn’t new — and neither are the solutions

BD to buy Edwards patient monitoring unit for $4.2 billion

https://cbu01.alicdn.com/img/ibank/2016/734/295/3137592437_2100374170.220x220xz.jpg

Structure Therapeutics oral GLP

Malaria cases in Florida and Texas: Here’s what you need to know

Take antibiotics after sex, CDC recommends for certain risk groups

United colonoscopy coverage change 'may cost lives,' doctors say

The most pressing bird flu mysteries scientists want answered

Wikipedia

BD to buy Edwards patient monitoring unit for $4.2 billion

Illumina board agrees to spin off Grail, as divestment plans proceed

Sutter Health’s antitrust win overturned by appeals court

An outdated Medicare rule harms dementia patients with anxiety

An outdated Medicare rule harms dementia patients with anxiety

FTC loses bid to block Novant's North Carolina hospital merger

hotspot

focus

Wikipedia

knowledge